OncoSignature™ standard drug screening service

Identify cells that respond to your therapeutics.

Screen compounds in up to 300 standard cancer cell lines in 2D or 3D formats with OncoSignature. Single agent or combination drug screening available, including 2D long-term assay (10 days).

Custom screening services

Create your own screen specifications. 

Benefit from our experience with combination therapeutic screens in complex or different disease type cells.

Preclinical screening platforms for Antibody-Drug Conjugate therapeutics - White Paper

Learn how to systematically evaluate antibody-drug conjugate (ADC) therapeutics through in vitro screening across diverse cell lines is essential for improving therapeutic efficacy and reducing off-target effects.

Learn more now

  • View our poster to see the benefits of using 3D systems to mimic tumor microenvironments
  • Read our brochure to learn more about OncoSignature™ and custom cell panel services

Contact us to discuss your next project


Required fields marked with * Required

Cell engineering and screening services ebook